Communiqués Codexis, Inc.

Actions

CDXS

US1920051067

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 05/10/2026			Varia. 5j.	Varia. 1 janv.
1,390 ^USD	+2,21%		+2,21%	-14,72%

28/09	Codexis, Inc. conclut un accord avec un pionnier des médicaments à base de petits ARN interférents (siRNA) afin d’exploiter la plateforme de fabrication ECO Synthesis pour créer des siRNA stéréodéfinis	CI
12/08	Transcript : Codexis, Inc., Q2 2026 Earnings Call, Aug 11, 2026

Communiqués

28/09	Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA	AQ
27/08	Codexis to Participate in Cantor Global Healthcare Conference 2026	AQ
11/08	Codexis: Q2 Earnings Snapshot	AQ
11/08	Codexis Reports Second Quarter 2026 Financial Results	AQ
03/08	Codexis Appoints David Butler, PhD, to Strategic Advisory Board	AQ
29/07	Codexis to Report Second Quarter 2026 Financial Results on August 11	AQ
28/07	Codexis to Report Second Quarter 2026 Financial Results on August 11	AQ
27/07	Codexis Announces Proposed Public Offering of Common Stock - July 23, 2026	AQ
27/07	Codexis Announces Pricing of Public Offering of Common Stock - July 23, 2026	AQ
27/07	Codexis Announces Pricing of Public Offering of Common Stock	AQ
24/07	Codexis Announces Pricing of Public Offering of Common Stock	AQ
23/07	Codexis Announces Proposed Public Offering of Common Stock	AQ
20/05	Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA	AQ
08/05	Codexis : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
07/05	Codexis: Q1 Earnings Snapshot	AQ
07/05	Codexis Reports First Quarter 2026 Financial Results	AQ
29/04	Codexis to share RNA manufacturing advances at TIDES USA	AQ
23/04	Codexis to Report First Quarter 2026 Financial Results on May 7	AQ
11/03	Codexis: Q4 Earnings Snapshot	AQ
11/03	Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results	AQ
25/02	Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11	AQ
17/02	Codexis to Participate in TD Cowen 46th Annual Health Care Conference	AQ
10/02	Codexis Achieves ISO 9001:2015 Certification	AQ
10/11	Codexis Announces Signing of Lease for GMP Manufacturing Facility	AQ
07/11	Codexis: Q3 Earnings Snapshot	AQ